Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
Key Details
- 1VIS-Fbs only emit fluorescence when bound to their target, reducing background by up to 100-fold.
- 2The technology allows tracking of multiple cellular targets simultaneously across the visible spectrum.
- 3Validated in various mammalian cells, neurons, astrocytes in mice, and zebrafish models.
- 4Certain VIS-Fbs are photo-switchable, supporting high spatial and temporal imaging precision.
- 5Published in Nature Methods; supported by multiple major biomedical funding bodies.
Why It Matters
VIS-Fb probes offer a major advance for live-cell and tissue imaging accuracy, enabling real-time, high-contrast visualization of molecular processes in complex biological systems. This innovation could improve fundamental research and precision imaging applications, including those relevant to disease modeling and radiology AI integration.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.